Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 14/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 5/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 4/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 4/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2514114 | 1.00 | PNMT (1.00) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL12280123 | 1.00 | PNMT (1.00) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL12280066 | 1.00 | PNMT (1.00) | PNMTADRA2AADRA2BADRA2C | |
| Iodide SCHEMBL2513362 | 0.98 | PNMT (0.96) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL30098010 | 0.93 | PNMT (0.86) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL20909872 | 0.79 | PNMT (0.66) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL8648256 | 0.78 | PNMT (0.64) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL5678366 | 0.78 | PNMT (0.64) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL12168266 | 0.78 | PNMT (0.64) | PNMTADRA2AADRA2BADRA2C | |
| SCHEMBL7516995 | 0.78 | PNMT (0.64) | PNMTADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720038-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024246496-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2024-12-05 | — | — | WO | disclosed |